ZB-16, a Novel GPR119 Agonist, Relieves the Severity of Streptozotocin–Nicotinamide-Induced Diabetes in Rats

ZB-16, a Novel GPR119 Agonist, Relieves the Severity of Streptozotocin–Nicotinamide-Induced Diabetes in Rats

GPR119 is involved in the regulation of incretin and insulin secretion, so the GPR119 agonists have been suggested as novel antidiabetic medications. The purpose of this work was to assess the influence of novel GPR119 agonist ZB-16 on the glucose utilization, insulin, and glucagon-like peptide-1 (G...

Full description

Bibliographic Details
Main Authors: Ivan N. Tyurenkov, Denis V. Kurkin, Dmitry A. Bakulin, Elena V. Volotova, Mikhail A. Chafeev, Alexey V. Smirnov, Evgeny I. Morkovin
Format: Article
Language:English
Published: Frontiers Media S.A. 2017-07-01
Series:Frontiers in Endocrinology
Subjects:
GPR119
ZB-16
diabetes mellitus
rodents
streptozotocin–nicotinamide diabetes
Online Access:http://journal.frontiersin.org/article/10.3389/fendo.2017.00152/full

Internet

http://journal.frontiersin.org/article/10.3389/fendo.2017.00152/full

Similar Items